All Categories
Catalog mRNA Products

Catalog mRNA Products

Home >  IVT RNA  >  Catalog Product  >  Catalog mRNA Products

All Categories

Catalog mRNA Products
Catalog saRNA Products
Catalog circRNA Products

Spike SARS-CoV-2 mRNA

  • Description
Inquiry

Is there a problem? Please contact us to serve you!

Inquiry

Spike SARS-CoV-2 mRNA expresses spike protein (S protein) of SARS-CoV-2 virus. The S protein on the surface of SARS-CoV-2 is a major antigen and its engagement with human ACE2 receptor plays an essential role in viral entry into host cells. The main candidate for COVID-19 vaccine development is the SARS-CoV-2 spike protein.

Yaohai Bio-Pharma offers unmodified or N1Ψ modified Spike SARS-CoV-2 mRNA, with Cap1 structure, optimized codons, engineered UTR and 110nt polyA tail, to improve mRNA stability and translation efficiency.

Product

Spike SARS-CoV-2 mRNA, Cap1, poly(A) tail, unmodified or modified mRNA

Product

Spike SARS-CoV-2 mRNA

Cat. No mP005
RNA Content 100 µg~10 mg (OD260)
Purity A260/A280
Identify and Purity Agarose Gel Electrophoresis (AGE)
5’Cap Cap1
3’ poly(A) tail 110±5 nt
Base Modification Unmodified, N1Ψ
Buffer RNase free water (liquid)
Shipping Ship with dry ice; or under ambient temperature
Storage

Liquid, at or below -20°C

Lyophilized powder, at 4°C

Application

Antigen gene

Other Customizable Options

5' Cap

Uncapped

Cap0, co-capped

Cap1, co-capped

Cap1, enzymatic capping

5’ UTR/3’ UTR

Nature UTR sequence

Mutant/Engineered UTR sequence

3' PolyA Tail

100A ~120A Tail (recommended)

Segmented polyA tail

Other custom tail

Modified nucleosides

Unmodified bases,

Pseudouridine (Ψ),

N1-Methylpseudouridine (N1Ψ),

5-methylcytosine (m5C),

5-methyluridine (m5U),

5-methoxyuridine (5moU),

2-thiouridine (s2U),

2′-O-methyl-U

Others

mRNA Preparation and Cell Expression

Taking linearized plasmid DNA (pDNA) harboring Spike SARS-CoV-2 mRNA coding genes as IVT template, we obtained pure Spike SARS-CoV-2 mRNA transcripts by co-transcriptional capping and purification, with cap1 structure and N1Ψ modification.

Pure Spike SARS-CoV-2 mRNA (1 μg) mixed with a commercial transfection reagent was transfected into 293T cells in a 96 well plate. And Western blotting (WB) was performed after 24 hours.

Spike SARS-CoV-2 mRNA manufacture

Expression of Spike SARS CoV-2 mRNA in 293T cells

Online Inquiry

If you have any suggestions, please contact us

Contact Us